KIR2DL1 - killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 1 Gene
Also Known as NKAT; NKAT1; p58.1; CD158A; KIR221; NKAT-1; KIR-K64; KIR2DL3
Species: Homo sapiens
About KIR2DL1
This gene has 2 transcripts (splice variants), 1 gene allele, 55 orthologues and 25 paralogues. Low expression observed in reference dataset.
Summary
Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. [provided by RefSeq, Jul 2008]
KIR2DL1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_014218.3 | NP_055033.2 | killer cell immunoglobulin-like receptor 2DL1 precursor |
| Molecular Function GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
8691146 | GOA |
| Biological Process GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| involved in natural killer cell inhibitory signaling pathway |
IDA
IDA: Inferred from direct assay
|
18604210 | GOA |
| Cellular Component GO Annotation | Evidence | Verweise | Source |
|---|---|---|---|
| located in plasma membrane |
IDA
IDA: Inferred from direct assay
|
18604210 | GOA |
KIR2DL1 Protein Structure
ig: Immunoglobulin domain (43 - 101)
ig: Immunoglobulin domain (142 - 199)
- 0
- 100
- 200
- 300
- 348 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
killer cell immunoglobulin-like receptor 2DL1 |
|
KIR2DL1 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | Verweise |
|---|---|---|---|---|---|---|---|
|
Intra
|
KIR2DL1 | P43626 | HLA-B | Homo sapiens | P01889 | 28546555 | |
|
Intra
|
KIR2DL1 | P43626 | HLA-C | Homo sapiens | P10321 | 18624290 | |
|
Intra
|
KIR2DL1 | P43626 | HLA-C | Homo sapiens | P10321 | 19858347 | |
|
Intra
|
KIR2DL1 | P43626 | HLA-C | Homo sapiens | P10321 | 28546555 | |
|
Intra
|
KIR2DL1 | P43626 | HLA-Cw | Homo sapiens | Q5RIP0 | 18322206 | |
|
Intra
|
KIR2DL1 | P43626 | HLA-C | Homo sapiens | Q7YQB1 | 18322206 |
Recombinant KIR2DL1 Proteins
| Art. -Nr. | Produktname | Accession | Reinheit |
|---|---|---|---|
| HY-P74792 | KIR2DL1 Protein, Human (HEK293, Fc) | P43626-1/NP_055033.2 (H22-H245) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P74793 | KIR2DL1 Protein, Human (HEK293, His) | P43626-1/NP_055033.2 (H22-H245) | ≥ 90%, as determined by reducing SDS-PAGE. |
| HY-P78165 | KIR2DL1 Protein, Human (Biotinylated, HEK293, His-Avi) | P43626-1 (H22-R242) | ≥ 95%, as determined by Bis-Tris PAGE. |
| HY-P78473 | KIR2DL1 Protein, Human (HEK293, His-Avi) | P43626-1 (H22-R242) | ≥ 95%, as determined by Bis-Tris PAGE. |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Duane Retraction Syndrome |
|
|
| Chronic Nk-Cell Lymphocytosis |
|
|
| Behcet Syndrome |
|
|
| Type 1 Diabetes Mellitus |
|
|
| Human Cytomegalovirus Infection |
|
|
| Leukemia, Acute Myeloid |
|
|